glp-1 receptor agonist fatigue side effects Glucagon-like peptide-1 agonists and muscle mass Updated Ranking and Side Effects
Description
Stimulation of this receptor leads to weight loss, improved glycemic control in diabetic patients, and improved cardiac and renal outcomes
Common clinical findings in these cases include: Persistent nausea and early satiety lasting weeks or months after discontinuation of the drug
The Phase 3 trial study results were based on trial participants who took the highest dose of 36 milligrams for more than a year, or approximately 17 months
Conway B, Miller RG, Costacou T, et al
Lets back up just a little and discuss how GLP-1 medications regulate blood sugar
